AbbVie Inc (ABBV)
Debt-to-capital ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 3,325,000 | 10,360,000 | 17,254,000 | 15,408,000 | 13,076,000 |
Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $3,325,000K)
= 0.00
AbbVie Inc's debt-to-capital ratio has been consistently reported as 0.00 from December 31, 2020, to December 31, 2024. A debt-to-capital ratio of 0.00 indicates that the company has either no debt or its debt level is negligible compared to its total capital, which comprises both debt and equity. This suggests that AbbVie Inc relies more on equity financing rather than debt to fund its operations and investments. A lower debt-to-capital ratio signifies a lower financial risk and financial leverage for the company. It also indicates a strong financial position and potentially favorable creditworthiness.
Peer comparison
Dec 31, 2024